The impact of antimicrobial resistance and capsular type distribution on the mortality of children under 5 years of age with invasive disease caused by Streptococcus pneumoniae;Impacto de la resistencia a antimicrobianos y de serotipos de Streptococcus pneumoniae en la mortalidad de ninos menores de 5 anos con enfermedad invasora

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 5, Issue 2, 1999, Pages 69-76

  Ríos, Ana María ^a,b   De La Hoz, Fernando ^a,b   Leal, Auta Lucía ^a,b   Castillo, Orlando ^a,b   Castañeda, Elizabeth ^a,b  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b NONE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G;

DRUG RESISTANCE; HEALTH IMPACT; MENINGITIS; MORTALITY; PNEUMONIA; RISK FACTOR;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY; PENICILLIN RESISTANCE; PNEUMONIA; REGRESSION ANALYSIS; RISK FACTOR; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

COLOMBIA;

EID: 0344959413     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49891999000200001     Document Type: Article

References (40)

1. Gray BM, Dillon Jr HC. Clinical and epidemiologic studies of pneumococcal infections in children. Pediatr Infect Dis J 1986;5(2):201-207.
2. Klein JO. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis 1981;3(2):246-253.
3. Finland M. Pneumococcal infections. En: Evans AS, Feldman HA, eds. Bacterial infections of humans: epidemiology and control. New York: Plenum Medical Books; 1982. pp. 417-433.
4. Garenne M, Ronsmaus C, Campbell H. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q 1992;45:180-191.
5. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15(1):77-83.
6. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3(2): 171-196.
7. Pallares R, Gudiol F, Linares J, Ariza J, Rufi G, Murgui L, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987;317(1):18-22.
8. Koornhof HJ, Wasas A, Klugman K. Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. Clin Infect Dis 1992;15(1):84-94.
9. Garcia Leoni ME, Cercenado E, Rodeño P, Bernaldo de Quirós JCL, Martínez-Hernández D, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992;14(2):427-435.
10. Istre GR, Tarpay M, Anderson M, Pryor A, Welch D. Invasive disease due to Streptococcus pneumoniae in an area with a high rate of relative penicillin resistance. J Infect Dis 1987;156(5):732-735.
11. Austrian R. Pneumococcal infections. En: Last JM, Wallace RB. Public health and preventive medicine. Norwalk Connecticut: Appleton Century Crofts; 1992: 87-89.
12. Hsueh PR, Wu JJ, Hslue TR. Invasive Streptococcus pneumoniae infection associated with rapidly fatal outcome in Taiwan. J Formos Med Assoc 1996;95(5): 364-371.
13. Calder MA, McHardy VU, Schonell ME. Importance of pneumococcal typing in pneumonia. Lancet 1970;1(7636):5-7.
14. Gray BM, Converse III GM, Dillon HC Jr. Serotypes of Streptococcus pneumoniae causing disease. J Infect Dis 1979;140(6): 979-983.
15. New vaccines: a pneumococcal vaccine to save children of all ages nears final testing. Children's Vaccine Initiative Forum 1996;13:3-11.
16. Montgomery JM, Lehmann D, Smith T, Michael A, Joseph B, Lupiwa T, et al. Bacterial colonization of upper tract and its association with acute lower tract infections in high-land children of Papua, New Guinea. Rev Infect Dis 1990;12 (Suppl 8):S1006-1016.
17. Castañeda E, Leal AL, Castillo O, De la Hoz F, Vela MC, Arango M, et al. Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Colombian Children. Microb Drug Resist 1997; 3(2): 147-152.
18. World Health Organization, Program for the Control of Acute Respiratory Infections. Technical bases for WHO recommendations on the management of pneumonia in children at first level health facilities. Geneva; 1991. (WHO/ARI/9120).
19. Karup Pedersen F, Henrichsen J. Pneumococcal meningitis and bacteremia in Danish children 1969-1978. Acta Path Immunol Scand 1983;Sect B 91:129-134.
20. Londoño JL. Análisis estratificado: metodologia de la investigación epidemiológica. Editorial Universidad de Antioquia; 1995.
21. Dean AG, Dean JA, Burton AH, et al. Epi Info Version 6.0: a word processing, database and statistics program for epidemiology on microcomputers. Atlanta, Georgia: Centers for Disease Control and Prevention; 1994.
22. Norusis MJ. SPSS Base para Windows, version 6.0. SPSS Inc; 1996.
23. Raffin TA. Intensive care unit survival of patients with systemic illness. Am Rev Respir Dis 1989;140(2, part 2):S28-S35.
24. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985;7(2):133-142.
25. Dagan R, Englehard D, Piccard E. Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. JAMA 1992;268(23):3328-3332.
26. Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks D. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990: ethnic differences and opportunities for prevention. J Infect Dis 1994;170(2):368-376.
27. Jacobs NM, Lerdkachornsuk S, Metzger WI. Invasive pneumococcal bacteremia in infants and children: a ten-year experience at the Cook County Hospital with special reference to the pneumococcal serotypes isolated. Pediatrics 1979;64(3): 296-300.
28. Kornelisse RF, Westerbeek CML, Spoor AB, van de Heijde B, Spanjaard L, Neijens HJ, de Groot R. Pneumoccal meningitis in children: prognostic indicators and outcome. Clin Infect Dis 1995;21(6): 1390-1397.
29. Ford H, Wright J. Bacterial meningitis in Swaziland: an 18 month prospective study and its impact. J Epidemiol and Community Health 1994;48(3):276-280.
30. Bennet NM, Buffington J, Marc La Force F. Pneumococcal bacteremia in Monroe County, New York. Am J Public Health 1992;82(11):1513-1516.
31. Pallares R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333(8):474-480.
32. Tan TQ, Mason EO, Kaplan SL. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics 1992;90(6):928-933.
33. Frankel RE, Virata M, Hardalo C, Altice FL, Friedland G. Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human inmunodeficiency virus infections. Clin Infect Dis 1996;23(3):577-584.
34. Sloas MM, Barrett FF, Chesney PJ et al. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1992;11(8):662-666.
35. Finch RG. Pneumonia: the impact of antibiotic resistance on its management. Microb Drug Resist 1995;1(2):149-158.
36. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin resistant and pencillin susceptible pneumococcal disease. Pediatr Infect Dis J 1995; 14(10):885-890.
37. Colombia, Ministerio de Salud, y Organización Panamericana de la Salud. Atencion del niño con infección respiratoria aguda. MS, OPS; 1992. (Serie Paltex no. 21).
38. Bédos JP, Chevret S, Chastang C, Geslin P, Régnier B. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis 1996;22(1): 63-72.
39. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular types and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 1992;60(1):111-116.
40. Fenoll A, Bourgon CM, Muñoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991;13(1):56-60.